A 21-year-old patient with pulmonary atresia and ventricular septal defect (PA-VSD) was admitted to the hospital for tubal ligation. Invasive arterial and central venous (CVP) pressure, pulse oximetric oxygen saturation (SpO2), and (from the tip of oximetric central venous catheter) central venous oxygen saturation (ScvO2) and oxygen extraction rate (ExO2) were continuously monitored. Heart rate (range: 68-75 beat/min), mean arterial pressure (80-90 mmHg), CVP (7-10 mmHg), SpO2 (79-90 percent), ScvO2 (57-70 percent), and ExO2 (21-30 percent) remained stable during epidural anesthesia and transvaginal sterilization. Following an overnight stay (peak SpO2 92 percent; peak ScvO2 71 percent; trough ExO2 21 percent), the oxygen data returned to baseline on awakening (SpO2 <80 percent, ScvO2 <55 percent, ExO2 >35 percent), and the patient was discharged. In PA-VSD, a single-outlet double-ventricle anomaly, CVP reflects the preload of systemic ventricle. As the mixed venous oxygen saturation cannot be defined, ScvO2 is the best available indicator of the whole body oxygen consumption. Continuous monitoring of CVP, ScvO2 and ExO2 in the superior vena cava may provide more insight into the response to anesthesia and surgery in patients with PA-VSD.
INTRODUCTION
Pulmonary atresia with ventricular septal defect (PA-VSD)d, previously classified as a variant of truncus arteriosus, is currently recognized as an extreme form of the tetralogy of Fallot. The pulmonary blood supply arises from the descending and, rarely, abdominal aorta, subclavian, pleural or coronary arteries. Morphology of the pulmonary perfusion varies widely, and the extreme form is characterized by atretic or hypoplastic nonconfluent pulmonary arteries and multiple, usually stenotic, aortopulmonary collaterals. The right ventricular outlet ends blindly and the venous blood is pumped through a large, usually infundibular VSD, directly into the overriding aorta [1] [2] [3] . An unrestricted rightleft intracardiac shunt and severe cyanosis characterize this single-outlet double-ventricle anomaly. The pulmonary blood flow (natural or surgical palliative) may become abundant and lead to pulmonary vascular disease and Eisenmenger syndrome [4] [5] [6] [7] . Life expectancy in PA-VSD is low, but rare patients survive up to the sixth decade. In previous years, a majority of infants were treated by a palliative surgical shunt only, until recently a complete surgical repair started to be recommended in selected cases [1-3, 8, 9] . Despite a low prevalence and a moderate survival rate into the adulthood, patients with PA-VSD are a To whom all correspondence should be addressed: Branko M. Weiss In the operating theater, ECG electrodes and a pulse oximetric probe were attached. Midazolam, 1 mg, was given intravenously. Radial artery (22 g ), lumbar extradural (16 g; at the level of L 2-3) and, through the right internal jugular vein, oximetric central venous catheters (Edslab, H-7.5F, Baxter, Irvine, CA) were placed under local anesthesia. Oxygen (5-8 L/min) was given by face mask. Optical module of the oximetric catheter, which uses double-wavelength fiberoptic reflection-spectrophotometry, and a pulse oximetric probe were connected to the corresponding instrument (Explorer, Baxter, Irvine, CA). ScvO2 from the catheter tip in the superior vena cava, pulse oximetry (SpO2), oxygen extraction rate (ExO2; provided through the SpO2-ScvO2 difference, neglecting the influence of P02 values), heart rate and an indicator of the oximetric signal quality were continuously displayed as digital values, figure lines and (Figures 2 and 3) . A total of 1600 mL of Ringer's lactate and 500 mL 6 percent hydroxyethyl starch solution was infused. At the end of operation, hemoglobin was 20.2 g/dL, hematocrit 61 percent, arterial pH 7.43, pO2 6.9 kPa (kPa = 7.502 mmHg), pCO2 4.6 kPa and base deficit -0.1 mmol/L. Analgesia was continued by an epidural infusion of bupivacaine 0.125 percent 4-8 mL/h and one dose of fentanyl 0.05 mg. Low-molecular-weight heparin was given subcutaneously, and midazolam 3.75 mg was given orally. Oxygen 4 L/min was provided by a nasal catheter. Following an overnight stay (peak SpO2, 92 percent; peak ScvO2, 71 percent; trough ExO2, 20 percent), the oxygen data returned to baseline on awakening (SpO2 <80 percent, ScvO2 <55 percent, ExO2 >35 percent; Figure 4 ). All catheters were removed, and the patient was discharged on the following day.
DISCUSSION
Limited oxygen availability and reduced exercise tolerance are characteristics of patients with cyanotic congenital heart disease [1-3, [12] [13] [14] . Laparoscopic sterilization under local anesthesia and monitored sedation has been recommended for these patients [15] . Initially a laparoscopic procedure was considered, but due to unpredictable response to the increased intrabdominal pressure and possible uncontrolled gas distribution, a decision was made to perform the tubal ligation transvaginally. A slow induction and titrated maintenance of epidural block were tolerated without difficulties [4, 6, 10, [16] [17] [18] [19] . CVP was considered crucial for the management of this patient, and the intravenous fluids were given correspondently. A transseptal pressure equalization in PA-VSD offers the opportunity to monitor the preload of the systemic (right and left) ventricle by extrapolating CVP for the right atrial and ventricular end-diastolic pressure. The ventricular function is prone to decompensation [1] [2] [3] , and the heart rate response to exercise (and anesthesia?) could be abnormally decreased in patients with PA-VSD [13] . Maintained CVP and heart rate were considered as a prime guarantee of sufficient cardiac output and systemic and pulmonary .................................................................... .... Figure 2 ) during the night after the procedure.
blood flow. A mild sedation contributed to calm spontaneous breathing and, at lower oxygen consumption, to high SpO2 and ScvO2 and low ExO2 during the procedure and natural sleep (Figures 2-4) . It seems that a near-maximal pulmonary blood flow and oxygenation were provided for the extreme form of PA-VSD. Further pharmacologic options, if required, are somewhat controversial [7, 10, 14, 16-18, 20, 21] . In PA-VSD and other anomalies without dynamic subvalvular obstructions, the drugs with positive chronotropic and inotropic properties should be preferentially used, as pure vasoconstrictors may provoke bradycardia, decrease the cardiac output and/or, directly acting on the aortopulmonary collaterals, further reduce the fragile pulmonary blood flow. Venous blood does not sufficiently mix in the right heart in PA-VSD, and the mixed venous oxygen saturation could not be defined in the presence of an intracardiac shunt. Systemic oxygen transport in cyanotic patients is predominantly dependent on blood flow (cardiac output) and much less on oxygen content. When exposed to decreasing oxygen delivery and with cardiac output near to or at the upper limit of maximal performance, the ExO2 rate must rapidly increase. ExO2 varies inversely with venous oxygen content and, in extreme situations, may exceed 50 percent [12] . In PA-VSD, ScvO2 from the superior caval blood reflects the oxygen supply/demand not only from the upper part but from the lower part of the body, as well. Sudden changes in the oxygen balance and an increased ExO2 below diaphragm will decrease the oxygen content in the inferior vena cava. A high inferior caval blood flow, representing roughly two-thirds of the cardiac output [22] , reaches the aorta through VSD and directly influences Sa02. Thus, an oxygen supply/demand imbalance in the lower part of the body will lead to an instant decrease of Sa02, followed by decreased ScvO2 and increased ExO2 in the superior vena cava. The actual caval oxygen contents, ExO2 and systemic oxygen delivery will depend individually on the duration and severity of oxygen debt, blood flow redistribution to preserve the cerebral and myocardial blood flow, Hb concentration, regional oxygen consumption [22] [23] [24] , additional load of pregnancy [4, 6, 11, 16, 25] and intercurrent therapeutic measures.
In conclusion, in addition to the monitoring of heart rate, ECG, arterial pressure and Sa/SpO2, a continuous measurement of CVP, ScvO2 and ExO2 in the superior vena cava may provide more insight into the hemodynamic response to anesthesia and surgery in patients with PA-VSD and similar congenital heart diseases.
